Penelope Kokkinides of InnovaCare Health Meets with President Trump to Debate about the Healthcare

InnovaCare Health is the leading facility when it comes to offering physician practice service and providing the best-managed health care services. The company offers a sustainable, smart and economical solution that combines the use of modern technology as well. Due to the massive network across the country, the company makes it easier for every individual to reach to their services. Their headquarters are located in Fort Lee, New Jersey.

 

Penelope Kokkinides is the InnovaCare Chief Administrative Officer and has helped in guiding to the success of the company and contributed noticeably to the company’s long list of achievements. In the past, she served as the Chief Operating Officer of InnovaCare Health. She was among the eight women who were invited to the panel with President Trump. Kokkinides pointed out the significance of increased aid for Medicare Benefit within Puerto Rico. She added that the current administration is considering changing to Medicare Advantage payment through CMS to help them conquer the some of the challenges they are facing. The major topics that were discussed at the meeting were the crucial role of a female in the healthcare industry. In the final notice released after the conference, CMS provided favorable amendment for the Puerto Rican medical care system.

 

Kokkinides has healthcare experience of more than twenty years specializing in managing healthcare industry and government programs. Previously, she has served in many executive roles including Executive Vice President for Centerlight Healthcare, where she was in charge of overall director of managed care division. She was also the COO of Touchstone Health and Vice President for Disease Management and Care at AmeriChoice.

 

Rick Shinto, the managing director, has an experience of over two decades in the industry with an in-depth knowledge of operational healthcare, managed care and clinical procedures. He brings much exposure to the firm and has managed to make both external and internal policies for the welfares of the customers and the organization. Previously, he had worked with different firms in the healthcare sectors such as Aveta Inc. where he served as the CEO and also as a member of hrmronline.com which is a healthcare portal. In 2012, Dr. Shinto received a prestigious and a highly reputed Young and Ernst Entrepreneur Award.

 

InnovaCare, Inc. offers managed healthcare services working on a leading operational health strategy in Puerto Rico with over 7,500 providers and serving over 200,000 members. The company is committed to providing quality healthcare to their members by creating sustainable models of management that are innovative, cost-effective, and fully integrated with advanced technologies.

 

Jim Tananbaum; The Future Of Medical Therapies

No business leader is as qualified academically as Jim Tananbaum. Jim boasts of an undergraduate in math and engineering from the renowned Yale College. Tananbaum holds an M.S. from M.I.T., an M.D. from the prestigious Harvard Medical College and a postgraduate M.B.A. from the business school of Harvard. He has held advisory positions on the boards of Harvard, MIT, and Yale.

In the business world, Jim has achieved a lot. He stands as the founder of Foresite Capital, a company that is redefining entrepreneurship in the sector of bio-pharmaceuticals. Jim has built Foresite Capital to the successful venture it is by creating partnerships and franchises with market leaders and innovators in the industry of healthcare. His business model involves strategic investment and management of enterprises that are focused on coming up with modern and efficient therapies.

Before the birth of Foresite Capital, Jim Tananbaum had already made milestones in the sector of bio-pharmaceuticals. His creation, Prospect Venture Partners II and III and Sierra Ventures came up with two drugs on a modest budget of $80 million. Other investments that Jim has led include Amira Pharmaceuticals, Jazz Pharmaceuticals, Healtheon, and Amerigroup.

Foresite Capital is also keen on the use of technology to advance futuristic medical therapies. Jim is positive that genomic sequencing will become an everyday medical practice in the future. Genomic sequencing will enable medical experts to design more targeting and individual specific treatments.

Jim Tananbaum is listed as one of the most influential business leaders by Forbes. One of the most notable success stories of Jim’s career in bio-pharmaceuticals is Intarcia. Intarcia is a bi-annual medical implant for individuals who are living with diabetes type II. The therapy enables them to manage their sugar levels and shed some weight. This product is expected to be available in the market by the end of the year 2017. Millions of people living with diabetes are supposed to get relief by using the therapy.

See more: https://www.linkedin.com/in/jim-tananbaum-a7562a7/